TransUnion (TRU) Q3 2026 Earnings Call Transcript

TransUnion reported Q3 revenue of $1.312 billion, up 12% reported and 8% organic constant currency, and adjusted diluted EPS of $1.25, up 14%; revenue, adjusted EBITDA and EPS exceeded the high end of prior guidance. The company raised the low end of full-year revenue guidance to $5.131 billion–$5.162 billion and expects adjusted EPS of $4.81–$4.88, while citing mortgage inquiry weakness, higher legal expenses and a projected roughly $60 million increase in 2027 net interest expense. TransUnion repurchased $126 million of shares in Q3, plans about $500 million in full-year repurchases, increased its quarterly dividend to $0.135 per share, and said a potential FHFA bi-merge shift could reduce annual revenue by about $33 million if all affected loans move to that standard.

Analysis

The operating signal is better than the headline EPS suggests: underlying growth excluding mortgage-score royalties is moderate, while repurchases and lower near-term interest expense amplify per-share growth. That distinction matters as the 2027 swap reset and higher SOFR create a roughly $60 million interest headwind; buybacks can cushion, not erase, the earnings drag. The margin reset also indicates that technology investment and FCRA-related legal costs are absorbing some growth leverage, so investors should demand evidence of platform-led revenue or cost benefits rather than capitalize migration savings in advance.

The most durable upside is diversification: insurance renewals, driving-history data, fraud products, and international expansion reduce dependence on U.S. mortgage pulls. But management’s growth-potential figures for new products are not contracted revenue. Near term, mortgage inquiry weakness and a potential bi-merge transition are manageable in stated direct exposure, yet share allocation among the three bureaus—not just total market shrinkage—is the second-order risk. VantageScore adoption could pressure FICO’s pricing power over time; FICO’s preferred program and commercial negotiations may slow that shift, so the path is not linear. EFX and Experian are exposed to the same bureau-selection dynamics, with no evidence here to call relative winners.

The contrarian risk is that strong reported growth and EPS obscure slower underlying U.S. financial-services momentum, margin investment, and a CFO handoff. Over 1–3 months, guidance delivery and mortgage inquiries matter; over 6–18 months, OneTru migration execution, international growth quality, score pricing, and legal expense trajectory determine whether the premium growth narrative earns support.

Key Decisions for Investors

• Prefer TRU over FICO on a relative basis, but size modestly and avoid treating the call as a clean short-FICO catalyst: monitor VantageScore adoption, realized score economics, and any disclosed FICO contract terms before adding. Reassess if adoption stalls or FICO preserves pricing without impairing bureau economics.
• For TRU, favor buying weakness rather than chasing the earnings reaction. The 1–3 month checkpoints are Q4 revenue excluding FICO royalties, mortgage inquiries, and underlying margin; a miss to the guided range or further underlying margin deterioration would invalidate the near-term constructive view.
• Keep EFX and Experian on a relative-value watchlist, not as presumed losers or beneficiaries. Track lender/reseller bureau selection and mortgage report mix; the risk is unequal share loss under bi-merge even if industry-wide revenue exposure is limited.
• For 2027 estimates, explicitly model the approximately $60 million net-interest increase and test whether operating growth and repurchases offset it. Also monitor CFO succession, FCRA litigation costs, and OneTru migration milestones; delay extrapolating platform savings until margins or product growth demonstrate them.